Menu
Sign up
Login
Menu
Sign up
Login
The step from drug discovery to clinical development is one of the most challenging hurdles, but also one of the most value gaining transformation of a potential drug.... → read more
January 3, 2022 from 1:04 PM CET to 6:00 PM CET
Join us live to discuss the specific challenges associated with the synthesis and manufacture of Highly Potent Active Pharmaceutical Ingredients (HPAPIs) in early process development phases.... → read more
November 30, 2021 at 4:00 PM CET
Test - Whole registration and log in process... → read more
January 11, 2022 at 4:45 PM CET
You can download presentations and watch recordings for every event session — including Q&A’s — on-demand from the comfort of your living room.
The NUVISAN group is a Contract Research Organization (CRO) and Contract Manufacturing Organization (CDMO) with its headquarters in Neu-Ulm and six sites in Germany and France (Neu-Ulm, Berlin, Grafing, Gauting, Waltrop and Sophia-Antipolis) in addition to monitoring activities with offices in Argentina, Peru and Brazil as well as in the USA.
NUVISAN offers integrated and coupled services and solutions along the drug development value chain from target identification to the patient with all supporting services (DMPK, GMP synthesis, formulation development and analysis, bioanalysis, Phase 1 CPU, clinical trial supplies and monitoring).
The NUVISAN team is happy to support you.
For sales enquiries, please schedule a meeting HERE or email us at hello@nuvisan.com.
For technical issues, please email us at marketing@nuvisan.com or call +49 731 9840 111.
